Reviewing the Science About Vitamin D vs COVID-19 Vaccine

Share the Truth!
Share on Facebook
Facebook
Tweet about this on Twitter
Twitter

Vitamin D clinical trials show major survival benefits and decreases in ICU admission rates! This vitamin is essential for a properly functioning immune response. Why are the US and even the World Health Organization officials ignoring the science of essentials and parroting the religious mantra that a vaccine will be our “savior?” 

The results of the study were astounding! 

Out of 50 patients treated with calcifediol ( immediately active form of “Vit D”) only 1 required admission to the ICU (2%) with no one dying. 

Of the 26 untreated patients, 13 required admission (50%) with 2 deaths (7.6%).

Of the patients treated with calcifediol, none died, and all were discharged, without complications but yet this science seems to be ignored by the medical community and the US government…Why?

Resources / References:

Covid: Free Vitamin D pills for 2.5 million vulnerable in England

https://www.bbc.com/news/health-55108613

Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis

https://pubmed.ncbi.nlm.nih.gov/30675873/

Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data

https://www.bmj.com/content/356/bmj.i6583

New evidence that vitamin D prevents respiratory infections

https://www.medicalnewstoday.com/articles/315886

Covid-19: Vaccine candidate may be more than 90% effective, interim results indicate

https://www.bmj.com/content/371/bmj.m4347

Vitamin D and the Immune System

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166406/

Severe vitamin D deficiency in patients with Kawasaki disease: a potential role in the risk to develop heart vascular abnormalities?

https://pubmed.ncbi.nlm.nih.gov/25994612/

“Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study”

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456194/

Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study)

https://pmj.bmj.com/content/early/2020/11/12/postgradmedj-2020-139065

Preventive Effects of Vitamin D on Seasonal Influenza A in Infants: A Multicenter, Randomized, Open, Controlled Clinical Trial

https://pubmed.ncbi.nlm.nih.gov/29315160/

Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results

https://pubmed.ncbi.nlm.nih.gov/32880651/

Low serum 25‐hydroxyvitamin D (25[OH]D) levels in patients hospitalised with COVID‐19 are associated with greater disease severity

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361912/

25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2

https://pubmed.ncbi.nlm.nih.gov/32397511/

Vitamin D to prevent COVID‐19: recommendations for the design of clinical trials

https://febs.onlinelibrary.wiley.com/doi/10.1111/febs.15534

Immune Modulatory Effects of Vitamin D on Viral Infections

https://pubmed.ncbi.nlm.nih.gov/32967126/

Share the Truth!
Share on Facebook
Facebook
Tweet about this on Twitter
Twitter

Leave a Reply

Your email address will not be published. Required fields are marked *